deferoxamine has been researched along with nitrilotriacetic acid in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (35.48) | 18.7374 |
| 1990's | 14 (45.16) | 18.2507 |
| 2000's | 3 (9.68) | 29.6817 |
| 2010's | 3 (9.68) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jacobs, A; White, GP | 1 |
| Haldar, K; Sanchez-Lopez, R | 1 |
| Abdallah, M; Brissot, P; Hubert, N; Jego, P; Lescoat, G; Morel, I; Ocaktan, A; Pasdeloup, N | 1 |
| Furukawa, T; Kohno, H; Naitoh, Y; Taketani, S; Tokunaga, R | 1 |
| Kawabata, T; Liu, M; Okada, S | 1 |
| Baker, E; Richardson, D | 1 |
| Evans, PF; King, LJ; Parke, DV; Preece, NE | 1 |
| Hider, RC; Porter, JB; Singh, S | 1 |
| Hamazaki, S; Li, JL; Midorikawa, O; Okada, S; Toyokuni, S | 1 |
| Ben-Shachar, D; Finberg, JP; Youdim, MB | 1 |
| Chevion, M; Katzhendler, J; Kohen, R; Korbashi, P | 1 |
| Basford, D; Goddard, JG; Sweeney, GD | 1 |
| Chevion, M; Kohen, R | 1 |
| De Matteis, F; Ferioli, A; Harvey, C | 1 |
| Hourahane, D; Jones, BM; Worwood, M | 1 |
| Pollack, S; Ruocco, S | 1 |
| Gokce, A; Nakamura, RM; Tubis, M; Wolf, W | 1 |
| Gould, BL; Langerman, N | 1 |
| Akiyama, T; Okada, S; Sarker, AH; Seki, S; Watanabe, S | 1 |
| Olivieri, NF; Parkes, JG; Randell, EW; Templeton, DM | 1 |
| Boadle, RA; Chen, J; Harris, DC; Nankivell, BJ | 1 |
| Brunner, G; Deepe, GS; Gootee, L; Newman, SL | 1 |
| Aubailly, M; Morlière, P; Risler, A; Salmon, S; Santus, R | 1 |
| Moos, T; Morgan, EH | 1 |
| Andrei, G; Boelaert, JR; Dieye, T; Farber, CM; Heenen, M; Hermans, P; Lambert, C; Liesnard, C; Lunardi-Yskandar, Y; Noel, JC; Parent, D; Simonart, T; Snoeck, R; Van Vooren, JP | 1 |
| Adachi, Y; Nakahashi, Y; Taketani, S | 1 |
| Aldieri, E; Bosia, A; Costamagna, C; Fenoglio, I; Fubini, B; Ghigo, D; Pescarmona, G; Prandi, L; Tomatis, M | 1 |
| Bonkovsky, HL; Hou, WH; Lambrecht, RW; Rossi, L; Shan, Y; Zheng, JY | 1 |
| Girardot, C; Peyton, BM; Sani, RK; Spycher, N; Stewart, BD | 1 |
| Alta, EC; Espósito, BP; Goswami, D; Machini, MT; Nomura, CS; Silvestre, DM | 1 |
| Chung, WY; Fiordalisi, C; Kowdley, KV; Messner, DJ; Surrago, C | 1 |
31 other study(ies) available for deferoxamine and nitrilotriacetic acid
| Article | Year |
|---|---|
Iron uptake by Chang cells from transferrin, nitriloacetate and citrate complexes: the effects of iron-loading and chelation with desferrioxamine.
Topics: Cells, Cultured; Citrates; Deferoxamine; Iron; Iron Chelating Agents; Liver; Nitrilotriacetic Acid; Transferrin | 1978 |
A transferrin-independent iron uptake activity in Plasmodium falciparum-infected and uninfected erythrocytes.
Topics: Animals; Biological Transport; Cells, Cultured; Culture Media; Deferoxamine; Erythrocytes; Humans; Iron; Nitrilotriacetic Acid; Plasmodium falciparum; Transferrin | 1992 |
Inhibition of iron overload toxicity in rat hepatocyte cultures by pyoverdin Pf, the siderophore of Pseudomonas fluorescens.
Topics: Amino Acid Sequence; Animals; Cells, Cultured; Deferoxamine; Ferric Compounds; Iron; Iron Chelating Agents; Liver; Molecular Sequence Data; Nitrilotriacetic Acid; Oligopeptides; Pigments, Biological; Pseudomonas fluorescens; Rats; Rats, Inbred Strains | 1992 |
Iron deprivation decreases ribonucleotide reductase activity and DNA synthesis.
Topics: Antibodies, Monoclonal; Cell Division; Deferoxamine; DNA; Ferric Compounds; Humans; Iron Deficiencies; Leukemia, Erythroblastic, Acute; Nitrilotriacetic Acid; Receptors, Transferrin; Ribonucleotide Reductases; Tumor Cells, Cultured | 1992 |
Radical-promoting "free" iron level in the serum of rats treated with ferric nitrilotriacetate: comparison with other iron chelate complexes.
Topics: Animals; Deferoxamine; Edetic Acid; Ferric Compounds; Free Radicals; Iron; Iron Chelating Agents; Lipid Peroxidation; Male; Nitrilotriacetic Acid; Rats; Rats, Inbred Strains | 1991 |
The uptake of inorganic iron complexes by human melanoma cells.
Topics: Ammonium Chloride; Antibodies, Monoclonal; Antigens, Neoplasm; Cell Membrane; Citrates; Citric Acid; Deferoxamine; Humans; Iron; Iron Chelating Agents; Kinetics; Melanoma; Melanoma-Specific Antigens; Neoplasm Proteins; Nitrilotriacetic Acid; Receptors, Transferrin; Transferrin; Tumor Cells, Cultured | 1991 |
Effects of glutathione depletion, chelation and diuresis on iron nitrilotriacetate-induced lipid peroxidation in rats and mice.
Topics: Animals; Buthionine Sulfoximine; Chelating Agents; Deferoxamine; Diuretics; Ferric Compounds; Furosemide; Glutathione; Kidney; Lipid Peroxidation; Liver; Male; Malondialdehyde; Methionine Sulfoximine; Nitrilotriacetic Acid; Oxidation-Reduction; Rats; Rats, Inbred Strains; Species Specificity | 1990 |
A direct method for quantification of non-transferrin-bound iron.
Topics: Acetates; Blood Proteins; Chromatography, High Pressure Liquid; Deferoxamine; Humans; Iron; Iron Chelating Agents; Molecular Weight; Nitrilotriacetic Acid | 1990 |
Oxygen reduction and lipid peroxidation by iron chelates with special reference to ferric nitrilotriacetate.
Topics: Adenosine Diphosphate; Animals; Ascorbic Acid; Deferoxamine; Edetic Acid; Ferric Compounds; Iron Chelating Agents; Linoleic Acid; Linoleic Acids; Lipid Peroxidation; Liposomes; Membrane Lipids; Micelles; Microsomes, Liver; NADP; Nitrilotriacetic Acid; Oxidation-Reduction; Oxygen; Pentetic Acid; Rats; Rats, Inbred Strains | 1989 |
Effect of iron chelators on dopamine D2 receptors.
Topics: 2,2'-Dipyridyl; Anemia, Hemolytic; Animals; Caudate Nucleus; Copper; Deferoxamine; Dihydroalprenolol; Ferrous Compounds; Iron Chelating Agents; Kinetics; Male; Nitrilotriacetic Acid; Phenanthrolines; Phenylhydrazines; Rats; Receptors, Adrenergic, beta; Receptors, Dopamine; Spiperone; Triazines | 1985 |
Iron mediates paraquat toxicity in Escherichia coli.
Topics: Catalase; Deferoxamine; Drug Synergism; Enzyme Induction; Escherichia coli; Histidine; Hydroxides; Hydroxyl Radical; Iron; Mannitol; Mathematics; Nitrilotriacetic Acid; Paraquat; Superoxide Dismutase | 1986 |
Lipid peroxidation stimulated by iron nitrilotriacetate in rat liver.
Topics: Adenosine Diphosphate; Animals; Butylated Hydroxyanisole; Deferoxamine; Ethane; Ferric Compounds; Free Radicals; Iron; Lipid Peroxides; Luminescent Measurements; Male; Microsomes, Liver; Mitochondria, Liver; NAD; NADP; Nitrilotriacetic Acid; Oxidation-Reduction; Oxygen Consumption; Rats; Rats, Inbred Strains | 1986 |
Involvement of iron and copper in biological damage that is induced by oxygen free radicals.
Topics: Animals; Deferoxamine; Free Radicals; Mice; Nitrilotriacetic Acid; Oxygen; Paraquat; Rats; Species Specificity | 1985 |
Drug-induced accumulation of uroporphyrin in chicken hepatocyte cultures. Structural requirements for the effect and role of exogenous iron.
Topics: Acetamides; Acetanilides; Aminolevulinic Acid; Animals; Aroclors; Cells, Cultured; Chick Embryo; Chlorodiphenyl (54% Chlorine); Deferoxamine; Dicarbethoxydihydrocollidine; Ferric Compounds; Iron; Liver; Metyrapone; Nitrilotriacetic Acid; Porphyrins; Uroporphyrins | 1984 |
Accumulation and release of isoferritins during incubation in vitro of human peripheral blood mononuclear cells.
Topics: Cells, Cultured; Concanavalin A; Deferoxamine; Ferric Compounds; Ferritins; Humans; L-Lactate Dehydrogenase; Leukocytes; Lymphocytes; Monocytes; Nitrilotriacetic Acid; Phagocytosis; Time Factors | 1984 |
Synergistic effect of nitrilotriacetate on iron mobilization by desferrioxamine in vivo.
Topics: Acetates; Animals; Binding Sites; Deferoxamine; Drug Synergism; Female; Iron; Mannitol; Nitrilotriacetic Acid; Rats | 1981 |
Synthesis of indium-labeled antibody-chelate conjugates for radioassays.
Topics: Animals; Binding Sites, Antibody; Deferoxamine; Glutaral; Humans; Hydrogen-Ion Concentration; Immunoglobulin G; Indium; Isotope Labeling; Nitrilotriacetic Acid; Radioimmunoassay; Radioisotopes; Transferrin | 1982 |
A thermodynamic description of the binding of iron to ferrioxamine B in aqueous solutions.
Topics: Calorimetry; Deferoxamine; Ferric Compounds; Hydrogen-Ion Concentration; Iron; Iron Chelating Agents; Nitrilotriacetic Acid; Thermodynamics | 1982 |
Oxygen radical-induced single-strand DNA breaks and repair of the damage in a cell-free system.
Topics: Animals; Carbon-Oxygen Lyases; Cell-Free System; Deferoxamine; DNA; DNA Damage; DNA Polymerase I; DNA Repair; DNA-(Apurinic or Apyrimidinic Site) Lyase; Endodeoxyribonucleases; Exodeoxyribonucleases; Ferric Compounds; Hydrogen Peroxide; Hydroxyl Radical; Mice; Multienzyme Complexes; Nitrilotriacetic Acid; Plasmids; Sarcoma, Experimental | 1995 |
Modulation by iron loading and chelation of the uptake of non-transferrin-bound iron by human liver cells.
Topics: Biological Transport; Carcinoma, Hepatocellular; Cell Death; Deferiprone; Deferoxamine; Diffusion; Ferric Compounds; Humans; Iron; Iron Chelating Agents; Iron Radioisotopes; Kinetics; Liver; Liver Neoplasms; Nitrilotriacetic Acid; Pyridones; Quaternary Ammonium Compounds; Transferrin; Tumor Cells, Cultured | 1995 |
The role of tubular iron accumulation in the remnant kidney.
Topics: Animals; Creatinine; Deferoxamine; Disease Models, Animal; Electron Probe Microanalysis; Ferric Compounds; Infarction; Iron; Kidney; Kidney Failure, Chronic; Kidney Tubules, Proximal; Lysosomes; Male; Microscopy, Electron; Nephrectomy; Nitrilotriacetic Acid; Proteinuria; Rats; Rats, Wistar; Reactive Oxygen Species; Transferrin | 1994 |
Chloroquine induces human macrophage killing of Histoplasma capsulatum by limiting the availability of intracellular iron and is therapeutic in a murine model of histoplasmosis.
Topics: Animals; Cells, Cultured; Chloroquine; Deferoxamine; Ferric Compounds; Histoplasma; Histoplasmosis; Humans; Iron; Macrophages; Male; Mice; Mice, Inbred C57BL; Nitrilotriacetic Acid; Transferrin | 1994 |
Sensitization of skin fibroblasts to UVA by excess iron.
Topics: Cell Survival; Cells, Cultured; Deferoxamine; Dose-Response Relationship, Radiation; Ferric Compounds; Fibroblasts; Humans; Lipid Peroxidation; Nitrilotriacetic Acid; Radiation-Sensitizing Agents; Skin; Thiobarbituric Acid Reactive Substances; Ultraviolet Rays | 1997 |
Evidence for low molecular weight, non-transferrin-bound iron in rat brain and cerebrospinal fluid.
Topics: Aging; Animals; Binding Sites; Biological Transport; Blood-Brain Barrier; Body Weight; Brain; Deferoxamine; Ferritins; Iron; Male; Micropore Filters; Molecular Weight; Nitrilotriacetic Acid; Organ Size; Precipitin Tests; Rats; Rats, Wistar; Transferrin | 1998 |
Iron as a potential co-factor in the pathogenesis of Kaposi's sarcoma?
Topics: Carcinogens; Cell Division; Chelating Agents; Chlorides; Deferoxamine; Ferric Compounds; Fibroblast Growth Factor 2; Humans; Iron; Nitrilotriacetic Acid; Sarcoma, Kaposi; Skin Neoplasms; Tumor Cells, Cultured | 1998 |
Regulation of the expression of human ferrochelatase by intracellular iron levels.
Topics: Animals; Chelating Agents; Coproporphyrinogen Oxidase; COS Cells; Cytoplasm; Deferoxamine; Dose-Response Relationship, Drug; Escherichia coli; Ferric Compounds; Ferrochelatase; Gene Expression Regulation, Enzymologic; Heme; Humans; Immunoblotting; Iron; K562 Cells; Mitochondria; Mutagens; Nitrilotriacetic Acid; Plasmids; RNA, Messenger; Time Factors | 2000 |
Iron inhibits the nitric oxide synthesis elicited by asbestos in murine macrophages.
Topics: Animals; Asbestos, Crocidolite; Cell Line; Deferoxamine; Ferric Compounds; Gene Expression Regulation, Enzymologic; Kinetics; Macrophages, Alveolar; Mice; Neuroglia; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrilotriacetic Acid | 2001 |
Iron increases HMOX1 and decreases hepatitis C viral expression in HCV-expressing cells.
Topics: Basic-Leucine Zipper Transcription Factors; Carcinoma, Hepatocellular; Cell Line, Tumor; Deferoxamine; Fanconi Anemia Complementation Group Proteins; Ferric Compounds; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Viral; Heme Oxygenase-1; Hepacivirus; Hepatitis C; Humans; Iron; Liver Neoplasms; NF-E2-Related Factor 2; Nitrilotriacetic Acid; Oxidative Stress; Reactive Oxygen Species; RNA, Messenger; RNA, Small Interfering; Viral Proteins | 2009 |
Influence of chelating agents on biogenic uraninite reoxidation by Fe(III) (Hydr)oxides.
Topics: Chelating Agents; Chlorides; Deferoxamine; Edetic Acid; Ferric Compounds; Nitrilotriacetic Acid; Oxidation-Reduction; Shewanella putrefaciens; Uranium | 2013 |
Desferrioxamine-caffeine (DFCAF) as a cell permeant moderator of the oxidative stress caused by iron overload.
Topics: Antioxidants; Caffeine; Cell Membrane Permeability; Deferoxamine; Drug Evaluation, Preclinical; Ferric Compounds; Fluoresceins; Fluorescent Dyes; HeLa Cells; Humans; Iron Chelating Agents; Iron Overload; Molecular Structure; Nitrilotriacetic Acid; Oxidative Stress | 2014 |
Isolation and characterization of iron chelators from turmeric (Curcuma longa): selective metal binding by curcuminoids.
Topics: Aluminum; Animals; Binding, Competitive; Calcium; Cell Line; Chromatography, Affinity; Copper; Curcuma; Curcumin; Deferoxamine; Diarylheptanoids; Edetic Acid; Epithelial Cells; Ferric Compounds; Iron; Iron Chelating Agents; Kinetics; Liver; Magnesium; Manganese; Nitrilotriacetic Acid; Plant Extracts; Rats; Zinc | 2017 |